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Abstract
Introduction. Shared Decision-Making may facilitate information exchange, deliberation, and effective decision-
making, but no decision aids currently exist for difficult decisions in neurocritical care patients. The International
Patient Decision Aid Standards, a framework for the creation of high-quality decision aids (DA), recommends the
presentation of numeric outcome and risk estimates. Efforts are underway to create a goals-of-care DA in critically-
ill traumatic brain injury (ciTBI) patients. To inform its content, we examined physicians’ perceptions, and use of
the IMPACT-model, the most widely validated ciTBI outcome model, and explored physicians’ preferences for com-
municating prognostic information towards families. Methods. We conducted a qualitative study using semi-
structured interviews in 20 attending physicians (neurosurgery,neurocritical care,trauma,palliative care) at 7 U.S.
academic medical centers. We used performed qualitative content analysis of transcribed interviews to identify major
themes. Results. Only 12 physicians (60%) expressed awareness of the IMPACT-model; two stated that they ‘‘barely’’
knew the model. Seven physicians indicated using the model at least some of the time in clinical practice, although
none used it exclusively to derive a patient’s prognosis. Four major themes emerged: the IMPACT-model is intended
for research but should not be applied to individual patients; mistrust in the IMPACT-model derivation data; the
IMPACT-model is helpful in reducing prognostic variability among physicians; concern that statistical models may
mislead families about a patient’s prognosis. Discussion: Our study identified significant variability of the awareness,
perception, and use of the IMPACT-model among physicians. While many physicians prefer to avoid conveying
numeric prognostic estimates with families using the IMPACT-model, several physicians thought that they ‘‘ground’’
them and reduce prognostic variability among physicians. These findings may factor into the creation and implemen-
tation of future ciTBI-related DAs.
Keywords
shared decision making, goals-of-care decisions, prognosis, traumatic brain injury, critical care, outcomes, IMPACT-
model, qualitative research
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Critically ill traumatic brain injury (ciTBI) patients are
incapacitated. They depend on family members or health
care proxies as surrogate decision makers (‘‘surrogates’’)
for any medical decisions, including the life-or-death
(‘‘goals-of-care’’) decision about continuation of care or
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Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial
use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE
and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
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withdrawal-from-life-sustaining interventions. Surro-
gates make the goals-of-care decision based in part on
the patient’s long-term prognosis, which is typically com-
municated to the surrogates by physicians. Physicians
commonly rely on their own experience to derive an esti-
mate of prognosis, but may also apply predictions
obtained from validated prognostic models, such as the
intracerebral hemorrhage (ICH) score1,2 and FUNC
scores3 for patients with an ICH or the International
Mission for Prognosis and Analysis of Clinical Trials in
TBI (IMPACT) model4,5 for patients with TBI to obtain
an estimate for a patient’s severity of disease and long-
term prognosis.6,7 While the authors of these models rec-
ommend that these models should not be used for endor-
sing limitations of care or making treatment decisions
without also considering individual patient factors not
included in such scores,6,8,9 in clinical practice unfortu-
nately many physicians use them to inform clinical deci-
sion making.8
However, in ciTBI physicians vary considerably in
their perceptions of neurologic prognosis and with-
drawal-from-life-sustaining therapies.10–13 Goals-of-care
decisions lack standardization, and physicians are prone
to adding their personal opinions and biases based on
their impression of the patient when offering (or not
offering) certain treatments at their discretion.10,11,13 In
many other diseases, a more standardized and collabora-
tive approach to the communication of projected out-
comes, delineation of treatment options with their risk-
benefit ratios, as well as the systematic elicitation and
inclusion of patient values and preferences has been
achieved by the use of shared decision-making tools
(decision aids).14–17 Recently, two large professional
medical societies highlighted the need for shared deci-
sion making in the intensive care unit (ICU) to facili-
tate information exchange, deliberation, and effective
decision making.18 This approach has also been sug-
gested for difficult decisions in TBI.19 Currently, no
decision aid exists for goals-of-care decisions in ciTBI
patients or any other diseases in the neuro-ICU.17 The
International Patient Decision Aid Standards (IPDAS)
serves as a framework for the development, rating,
and certification of high-quality decision aids and
recommends a systematic approach, beginning with the
exploration of stakeholders’ (i.e., physicians’ and sur-
rogates’) communication practices and preferences for
decision making.20,21 Furthermore, this framework
advises the presentation of probabilities, such as those
derived from disease-specific validated outcome
models.21
In ciTBI, the IMPACT model remains the most
widely validated outcome model but has significant
weaknesses. It is based on admission criteria only and
does not include the clinical course of a patient after
admission, or response to supportive care in the ICU for
the first crucial 3 to 5 days. Therefore, the IMPACT
model may be poorly suited to be included in a future
goals-of-care decision aid for ciTBI, because potential
care-limiting decisions should not be based on prognostic
probabilities derived from admission criteria only.
However, to our knowledge, to date there is a paucity of
better ciTBI outcome prediction models, which include
the patient’s hospital course and response to treatment,
leaving the IMPACT model as a leading candidate for
use in a goals-of-care decision aid in ciTBI.
The objective of the current study was to examine phy-
sicians’ awareness, perceptions, and use of the IMPACT
model, as well as their preferences for communicating
prognostic estimates during family meetings with ciTBI
surrogates. The information gained from this study
would crucially inform the content and building of a
future goals-of-care decision aid in ciTBI.
Methods
Study Design and Participants
This current study is one component of a larger qualita-
tive study exploring key stakeholders’ (surrogate decision
makers and physicians) attitudes and preferences for out-
come prognostication for ciTBI patients, and its
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communication to families and surrogate decision mak-
ers22 that was conducted between October 2015 and
August 2016. Participating physicians were recruited
using purposive and snowball sampling from seven aca-
demic medical centers from five geographic regions of
the United States (Northeast, Mid-Atlantic, South, West,
and Midwest; Figure 1) representing four different spe-
cialties (neurosurgery, neurocritical care, trauma surgery,
and palliative care). Inclusion criteria included English-
speaking with willingness to undergo an audio-recorded
interview, caring for ciTBI patients, practicing as an
attending for 2 years after fellowship training, and rou-
tine engagement in goals-of-care discussions for ciTBI
patients.
The University of Massachusetts Medical School
(UMMS) Institutional Review Board approved the study
with written consent for in-person interviews (n = 10),
or verbal consent with an approved script for telephone
interviews (n= 10).
Measurements and Interviews
Baseline demographics were obtained using a written
survey. We developed a semistructured interview guide
with open-ended questions. To address the objectives of
our current study, one part of the interview guide was
aimed at exploring physicians’ communication practices
during family meetings of ciTBI patients discussing the
patient’s prognosis, as well as physicians’ awareness,
knowledge, use, and perception of the IMPACT model
to guide estimates of the patient’s prognosis. The inter-
view guide was iteratively refined with input from
content and physician-patient communication experts,
and tested in two mock interviews. The institutional
review board approved the final interview guide before
its use. One trained interviewer (SM) conducted all inter-
views in person or over the phone. All interviews were
digitally audio-recorded and transcribed verbatim by a
professional transcription service. Participants were
offered a $25 gift card for their participation.
Coding Procedures and Analysis
We developed a coding scheme using parallel deductive
and inductive methods. The initial coding scheme was
developed based on the interview guide content by a neu-
rointensivist (SM) and an experienced qualitative
researcher (KM). Two coders (TQ and JM) coopera-
tively coded five transcripts while making inductive
changes to the initial coding scheme when necessary,
with review of changes by SM and KM. Conceptually
similar themes were combined and emerging themes
added; conflicts were resolved using a third reviewer.
Using this revised coding scheme, coders then indepen-
dently coded the same three additional transcripts,
resulting in .80% congruency. All previous and subse-
quent transcripts were then coded separately using the
revised coding scheme, with no further inductive changes
required, indicating theme saturation (no new themes
emerged). All codes were reviewed by three authors to
ensure correct classification. Recruitment was continued
to diversify the sample and to confirm that indeed no
novel information would be obtained through the analy-
sis of several additional transcripts. Theme saturation
and feasibility resulted in a final sample size of 20 physi-
cians. Qualitative analysis was performed using NVIVO
(QSR International Pty Ltd., Melbourne, Australia).
Baseline characteristics of the study groups were sum-
marized using descriptive statistics.
Results
Baseline Characteristics
The average interview duration was 37 minutes (range =
19–65 minutes). Baseline characteristics of the study
cohort are shown in Table 1. The mean number of years
in attending practice was 14. Half of the participants
were specialized in neurocritical care, with the other half
distributed among neurosurgery, trauma, and palliative
care. The geographical location of participants is shown
in Figure 1. Of the approached physicians, one declined
participation.
Figure 1 Geographic distribution of participating physicians.
This map shows the number and location of participating
physicians in the United States.
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IMPACT Model Awareness and Use in Clinical
Practice
Overall, only 12 (60%) of the physicians expressed
awareness of the IMPACT model, of whom 8 were non-
surgical neurocritical care specialists. Of the 12 physi-
cians with knowledge of the IMPACT model, 7 indicated
using the model at least some of the time to form a
patient’s prognosis in clinical practice, although none
used it exclusively to derive a prognosis. One physician
mentioned he/she might show the output from the
IMPACT model to select families ‘‘once in a while if
there is a family that is very number-oriented and they
want percentages.’’ Of the seven neurosurgeons inter-
viewed, three expressed awareness of the IMPACT
model, of whom one was ‘‘barely aware,’’ and one
acknowledged its use for discussions among physicians,
but not with families. Of the two trauma surgeons, only
one stated that he/she ‘‘had heard about’’ the IMPACT
model, but was not using it for prognostication due to
lack of familiarity with this model.
Major Themes
We identified four major themes representing a variety
of views on the communication practices of numeric esti-
mates of the patient’s prognosis during family meetings
and the utility of the IMPACT model for ciTBI prognos-
tication and clinical decision making. When physicians
were unaware of the IMPACT model specifically, we
included general statements about the use of health out-
come models, as these statements included important
insights into the physicians’ perceptions of the utility of
outcome scores for neurological prognostication. Below
we list each theme with a representative quote. Additional
quotes for each theme are shown in Table 2.
The IMPACT Model (Outcome Scores in General) Are
Research Tools and Should Not Be Used in Individual
Patients. Many physicians expressed significant appre-
hension about applying the IMPACT model to individ-
ual patients. Specifically mentioned was the opinion that
the IMPACT model and other outcome scores are
research tools and were designed to inform clinical trial
design, but should not be applied at the bedside to an
individual. As one physician stated,
I am always very scared when I hear of colleagues trying to
use the IMPACT calculator or the CRASH calculator.
These things were never designed for clinical decision mak-
ing, they were designed to inform clinical trial design.
Mistrust in the IMPACTModel Data. Several physicians
raised concern about the quality of the data underlying
the IMPACT model, as well as the quality of the data
generated by TBI outcome research in general due to het-
erogeneity among the different injury patterns and the
stratification into different TBI severities by the Glasgow
Coma Scale. This mistrust in TBI outcome data also rep-
resented the main reason for physicians not applying the
IMPACT-model in clinical practice:
I don’t think the data is really good. I think for me TBI is
probably the most difficult disease to prognosticate and I do
not think that any of the decision tools that we have person-
ally are very good. . . . I do not think the disease has been
studied very well.
Even physicians who were not aware of the IMPACT
model expressed a genuine concern and mistrust in using
any prognostic models and calculators for the determina-
tion of a patient’s prognosis:
I do not put any stake in the calculators that are out there
right now.
There’s not a lot of science available really—Prognosis in
TBI is really not clear cut.
The IMPACT Model Is Helpful in Reducing Physician
Variability in a Heterogeneous Disease. Despite the
Table 1 Participating US Physicians’ Baseline Characteristics
(N= 20)
Baseline Characteristics Physicians
Age (years), mean 6SD 47 6 8
Female 7 (35)
Race
Caucasian 13 (65)
African American 1 (5)
Asian 6 (30)
Ethnicity
Non-Latino 19 (95)
Latino 1 (5)
No. of years in attending practice,
mean 6SD (range)
14 6 10 (2–40)
Specialty
Neurocritical care 10 (50)
Neurosurgery 7 (35)
Trauma surgery 2 (10)
Palliative care 1 (5)
Note: Data are presented as n (%) unless otherwise specified.
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inherent mistrust in using the IMPACT model (or any
outcome model in general), all physicians acknowl-
edged the challenges in forming a prognosis reliably for
many of these critically ill patients. Therefore, several
physicians viewed the IMPACT model as helpful in
reducing the variability among physician opinions
when many different physicians and services are caring
for a patient:
I think it is helpful to ground the physicians a little bit. In
short, I think it reduces the variability of prognosis that a
large group of physicians may give to this very heteroge-
neous group of patients.
Several physicians warned that the IMPACT model
should not be used in isolation but in conjunction with
all available clinical data:
At times, we will also calculate an IMPACT score to add to
the clinical information we have about that patient. It is not
done in isolation but rather in conjunction with clinical
examination. . . . Putting that all together, we start to get a
good idea of how we feel the patient is doing.
Presenting Numbers Derived From Statistical Models
May Mislead Patient Families. A frequently mentioned
concern regarding the clinical use of the IMPACT model
for families was the reluctance by physicians to provide
numeric prognostic estimates to families. Participants
stated several reasons for this concern. The first reason
was the assumption that families will misinterpret
numeric estimates due to stress and despair, thereby cre-
ating false hope and unfounded optimism:
Percentages will be interpreted by families in whatever way
they want. Even if you give them the 80% chance of mortal-
ity, if they’re optimistic, they will latch on to the 20%.
In addition, physicians expressed apprehension about
potentially low numeracy among surrogate decision mak-
ers, resulting in oversimplification of numeric estimates:
Family members, unless they are very mathematically
sophisticated, really don’t interpret these numbers the way
that physicians and scientists interpret these numbers. They
become simplified and used against you later.
Although a subgroup analysis of attitudes and awareness
of the IMPACT model by physician specialty was
considered, it was not performed due to the small sample
size.
Discussion
Our study found substantial variability in expert physi-
cians’ awareness, utilization, and perception of the
IMPACT model, but consistency in their reluctance to
use numeric prognostic estimates during family meetings.
These findings present both insights and challenges to
promoting informed decision making among surrogates
while illustrating physicians’ approaches to prognostica-
tion for ciTBI patients.11,13
With the creation of a ciTBI goals-of-care decision
aid in mind, which meets as many IPDAS criteria as pos-
sible, including the criteria to ‘‘present probabilities’’ for
the outcome prognostication,21 we purposefully exam-
ined physician responses to the IMPACT model as the
most widely validated prediction model in TBI.4,5,23,24
Parsimonious outcome models, in general, are not
designed to guide treatment decisions or limitations of
care, but due to their ease of use, in the reality of clinical
practice, physicians often turn to these tools for guidance
to inform clinical decision making and may misuse them
by applying them to individual patients.8 We found in
our study that most of the participating TBI expert phy-
sicians do not endorse the communication of probabil-
ities derived from the IMPACT model in a ciTBI
decision aid, while some find the model helpful in
grounding physicians in their prognostication.
Our findings are in line with a recent qualitative study
assessing attending physician attitudes and use of clinical
prediction models when discussing end-of-life care.
Physicians in that study reported that they use clinical
prediction models primarily to ‘‘validate’’ the prognosis
the physician had already derived to enhance their pre-
dictive confidence. However, similar to the results of our
study, physicians were hesitant to provide actual numeri-
cal data to patients and had concerns of promoting prog-
nostic overconfidence in end-of-life care.25
Other published literature has also raised caution
about the utility and appropriate use of prognostic
scores to guide treatment decisions and provide outcome
prognostication in neurological emergencies.8,26 Because
these scores are parsimonious by design, they omit
unique patient characteristics that might affect patient’s
prognosis such as preexisting comorbidities, including
cognitive decline, and major in-hospital complications.
Decisions based on prognostic scales that result in limita-
tions of care during the early phases of catastrophic
brain injuries, including TBI, may lead to clinical nihi-
lism and self-fulfilling prophecies.8,13,26 For example, in
patients with an ICH, a multicenter study of 742 neurol-
ogists and neurosurgeons showed that knowledge of the
Moskowitz et al. 7
ICH score considerably influenced physician decision
making and prognostication.7 The physicians’ prediction
of 30-day mortality and initial treatment intensity recom-
mendations changed significantly before and after the
ICH score was provided to them in two hypothetical
ICH cases. Recommendations for treatment limitations
were 60% higher when the ICH score suggested no
chance of functional independence, but were significantly
lower with an ICH score suggesting independence at 30
days. Similarly, another multicenter study in ICH
patients revealed that physician and nurse clinical judg-
ments correlated more closely with actual 3-month func-
tional patient outcomes than with two of the most
commonly applied ICH prognostic scores.9 In the setting
of ciTBI, prospective comparisons of patients’ outcomes
as predicted by the IMPACT score versus independent
clinician judgment have not been published. However,
in a large Italian TBI quality performance database
study, the actual ciTBI patient outcomes were consis-
tently better over the 11 years of collected data than
the outcomes predicted by the IMPACT model.27 This
research suggests that skepticism about the IMPACT
model expressed by the physicians in our study is
indeed warranted.
A second important concern raised by several partici-
pants in our study was mistrust in the data from which the
IMPACT model was derived. This mistrust may be based
on awareness that the IMPACT model explains only 35%
of the variability in outcomes after TBI.24 While the
IMPACT model has been externally validated,5,28 its
source data were combined from many observational stud-
ies and clinical trials of different patient populations, years
under study, and data quality.4,29 Therefore, in order to
achieve adequate power in the predictive model, the selec-
tion of variables affecting prognosis was limited to few
common variables collected in all source studies.30 This
recognition of the limitation of standardized data collec-
tion across research studies eventually led to the creation
of the TBI Common Data Elements.31–33 There are several
ongoing single- and multicenter prospective TBI studies
that are currently working on the development of more
precise TBI prediction models (TRACK-TBI, CENTER-
TBI, and OPTIMISM study) to include information about
the clinical inpatient course of a patient after admission,
and response to early supportive care.34–36
There are fundamental uncertainties involved in com-
municating individual risk estimates.37 Models that are
well calibrated to predict the outcomes of a large popula-
tion do not predict well (discriminate) for individuals.38
Predictive models are typically validated based on cali-
bration, not discrimination, although only discrimination
is the relevant standard if the model is intended for individ-
ual prediction.39 Our finding that physicians were reluctant
to use a model that was validated at the population level to
predict at the individual level may indicate their apprecia-
tion of the limitations of applying population-based risk
models to individuals.
The reluctance of physicians to present numeric prog-
nostic estimates derived from the IMPACT model is dis-
cordant to the communication preferences of surrogate
decision makers of ciTBI patients when discussing prog-
nosis. A recent study showed that surrogates felt that
prognostic probabilities help limit uncertainty and ambi-
guity, and hearing numeric estimates conveys more con-
fident decision making.22 A high numeracy and health
literacy level of the participating surrogate decision mak-
ers may have biased the results of this study, however.
This discordance between physician practice and surro-
gate preference regarding delivery of information about
prognosis in the setting of ciTBI requires further study.
Physicians in our study worried that families will not
adequately interpret the meaning of the numeric esti-
mates due to low numeracy and health literacy, high
stress levels, and false hope. Several studies have con-
firmed that surrogates may interpret prognostic esti-
mates with an optimistic bias.40,41 Reasons other than
simple misunderstandings of numerical risk information
are thought to underlie this optimistic bias; psychological
biases such as ‘‘the need to remain hopeful,’’ skepticism
in the physicians’ ability to accurately predict death, and
positive patient attributes as perceived by the surrogate,
but not low numeracy and health literacy, have been sug-
gested as some of the cognitive causes for optimistic
bias.40 Furthermore, only a very small proportion of sur-
rogates rely exclusively on prognostic information pro-
vided by physicians.41 Patient attributes greatly influence
surrogates’ own impression of the patient’s prognosis,
including strength of character, life history, appearance,
and faith.41 Furthermore, other research has shown that
neither surrogates’ personal estimates of the patient’s
outcome nor their understanding of the physician’s prog-
nostication differed between conveying the patient’s
long-term prognosis numerically versus qualitatively.42
For some patients or their surrogate decision makers,
conveying the ‘‘gist,’’ which is the qualitative, vague,
bottom-line meaning of the information, rather than a
numeric prognostication, may be preferred by physi-
cians, patients, and by their surrogates themselves.40,43,44
The perspectives captured from some of the physicians
in our study support this notion.
In contrast, however, presenting numeric prognostic
estimates to surrogate decision makers using the best
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available clinical prediction models, albeit imperfect and
with a large degree of uncertainty, has important
advantages. First, as recent research has shown, many
surrogate decision makers in ciTBI patients want to
know these numbers.22 Second, as physicians stated in
our study, clinical prediction models may help limit the
prognostic variability among physicians with different
experience levels and biases; they help ‘‘ground’’ them.
Third, avoiding the communication of probabilities
could suggest to families a lack of confidence in the
physician’s overall competence in caring for ciTBI
patients. The clear communication of probabilities and
the associated uncertainty appropriately tailored to the
family’s numeracy level is, however, a difficult skill to
learn and teach. Having a tool available that uses icon
arrays and images to convey this numeric information
may help.
As we develop a decision aid for the goals-of-care
decision in ciTBI patients, we have carefully weighed the
options of including or omitting the IMPACT model
from the decision aid. We are well aware of the limita-
tions of the IMPACT model and that the goals-of-care
decision, a possible treatment limiting decision, must not
be based on the admission variables only without consid-
ering the patient’s clinical course. However, complete
omission of the IMPACT model from the decision aid
would equal omission of all outcome probabilities from
the decision aid, given the current absence of a better
ciTBI outcome prediction model that includes elements
of a patient’s clinical course or response to supportive
ICU care over the first crucial 3 to 5 days after TBI.
Such omission would be against the IPDAS criteria, and
clearly against what families and surrogate decision mak-
ers need.22 Therefore, we are considering including the
IMPACT model in the decision aid, well knowing that
we must also explain the uncertainty associated with it,
as it only includes admission criteria. One possible con-
sideration is to use the IMPACT model to calculate the
predicted mortality and poor outcome at 6 months
(IMPACT predicts only these two dichotomized out-
comes), provide this information to the physician who is
going to discuss goals-of-care in order to ‘‘ground them,’’
and encourage the physician to add additional elements
derived from the clinical course not included in the
IMPACT model, such as response to treatment in the
first few days, certain severe in-hospital complications
(e.g., cardiac arrest, need for renal replacement therapy,
refractory increased intracranial pressure, ischemic
stroke from herniation),36 preexisting comorbidities, or
cognitive status before the TBI. Physicians may then
‘‘tweak’’ the prognosis to the better or worse from the
‘‘base’’ prognosis derived from the IMPACT model
before it is included and presented in the decision aid to
the patient’s family. As the ongoing TRACK-TBI,
CENTER-TBI, and OPTIMISM studies34–36 yield
improved prediction models, we will update the decision
aid with this new information. This approach is one of
many possible approaches to the described outcome pre-
diction dilemma in patients with TBI and has been mod-
eled by the inventors of a decision aid for families of
chronically ventilated medical ICU patients.45
Study Strengths and Limitations
Our study has several strengths and limitations. We
recruited physicians from across the United States repre-
senting five geographical areas, with overrepresentation
from the East Coast, and underrepresentation of African
American and Latino physicians. Physicians from these
racial and ethnic backgrounds, and those from other
areas of the United States and the world, may have dif-
ferent experiences, views, and approaches to communi-
cating prognosis, which we may not have fully captured.
We reached theme saturation after interviews with 20
physicians, which may seem small, but is a sample size
that is typical for qualitative interview studies. It was
designed to uncover some of the key issues in this area
but not to produce generalizable results. Half of our
cohort included nonsurgical neurointensivists, while the
surgical participants were recruited from neurosurgery
and trauma. It is possible that there may have been dif-
ferences between these surgeons and nonsurgical physi-
cians in the awareness, use, and perception of the
IMPACT model. Half of our participants were recruited
from a single center (UMMS). Therefore, it is possible
that the institutional culture and center-specific practices
may have biased the results. However, given the similari-
ties of the physician comments from this and other study
sites, our results likely represent findings that are not
center-specific. Finally, the reservations expressed by
physicians regarding the use of the IMPACT model may
not be generalizable to all models in neurocritical care or
models outside of this field.
In summary, our study identified significant variabil-
ity of the awareness, perception, and use of the IMPACT
model among physicians. While many physicians prefer
to avoid conveying numeric prognostic estimates with
families using the IMPACT model, several physicians
thought that they ‘‘ground’’ them and reduce prognostic
variability among physicians. These findings may factor
into the creation and implementation of future ciTBI-
related decision aids. Furthermore, research efforts
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should continue to focus on accumulating reliable ciTBI
outcome data.
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